Batten disease is inherited disorder of the nervous system which begins in childhood. It is also called as neuronal ceroid lipofuscinoses (or NCLs).
The Batten Disease market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Batten Disease industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Batten Disease market can be split based on product types, major applications, and important countries as follows:
Key players in the global Batten Disease market covered in Chapter 12:
Seneb BioSciences.
Abeo Therapeutics
Ionis Pharmaceuticals
BioMarin Pharmaceuticals
Evotec AG
CereSpir Inc
RegenxBio
Mitochon Pharmaceuticals
Spark Therapeutics
Polaryx Therapeutics
In Chapter 4 and 14.1, on the basis of types, the Batten Disease market from 2015 to 2025 is primarily split into:
Occupational Therapies
Physical Therapies
In Chapter 5 and 14.2, on the basis of applications, the Batten Disease market from 2015 to 2025 covers:
Infantile NCL
Late Infantile NCL
Juvenile NCL
Adult NCL
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Batten Disease Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Batten Disease
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Batten Disease industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Batten Disease Market Size, 2015 - 2020
2.1.2 Global Batten Disease Market Size by Type, 2015 - 2020
2.1.3 Global Batten Disease Market Size by Application, 2015 - 2020
2.1.4 Global Batten Disease Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Batten Disease Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Batten Disease Analysis
3.2 Major Players of Batten Disease
3.3 Batten Disease Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Batten Disease
3.3.3 Labor Cost of Batten Disease
3.4 Market Distributors of Batten Disease
3.5 Major Downstream Buyers of Batten Disease Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Batten Disease Market, by Type
4.1 Global Batten Disease Value and Market Share by Type (2015-2020)
4.2 Global Batten Disease Production and Market Share by Type (2015-2020)
4.3 Global Batten Disease Value and Growth Rate by Type (2015-2020)
4.3.1 Global Batten Disease Value and Growth Rate of Occupational Therapies
4.3.2 Global Batten Disease Value and Growth Rate of Physical Therapies
4.4 Global Batten Disease Price Analysis by Type (2015-2020)
5 Batten Disease Market, by Application
5.1 Downstream Market Overview
5.2 Global Batten Disease Consumption and Market Share by Application (2015-2020)
5.3 Global Batten Disease Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Batten Disease Consumption and Growth Rate of Infantile NCL (2015-2020)
5.3.2 Global Batten Disease Consumption and Growth Rate of Late Infantile NCL (2015-2020)
5.3.3 Global Batten Disease Consumption and Growth Rate of Juvenile NCL (2015-2020)
5.3.4 Global Batten Disease Consumption and Growth Rate of Adult NCL (2015-2020)
6 Global Batten Disease Market Analysis by Regions
6.1 Global Batten Disease Sales, Revenue and Market Share by Regions
6.1.1 Global Batten Disease Sales by Regions (2015-2020)
6.1.2 Global Batten Disease Revenue by Regions (2015-2020)
6.2 North America Batten Disease Sales and Growth Rate (2015-2020)
6.3 Europe Batten Disease Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Batten Disease Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Batten Disease Sales and Growth Rate (2015-2020)
6.6 South America Batten Disease Sales and Growth Rate (2015-2020)
7 North America Batten Disease Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Batten Disease Sales, Revenue and Market Share by Countries
7.2.1 North America Batten Disease Sales by Countries (2015-2020)
7.2.2 North America Batten Disease Revenue by Countries (2015-2020)
7.3 United States Batten Disease Sales and Growth Rate (2015-2020)
7.4 Canada Batten Disease Sales and Growth Rate (2015-2020)
7.5 Mexico Batten Disease Sales and Growth Rate (2015-2020)
8 Europe Batten Disease Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Batten Disease Sales, Revenue and Market Share by Countries
8.2.1 Europe Batten Disease Sales by Countries (2015-2020)
8.2.2 Europe Batten Disease Revenue by Countries (2015-2020)
8.3 Germany Batten Disease Sales and Growth Rate (2015-2020)
8.4 UK Batten Disease Sales and Growth Rate (2015-2020)
8.5 France Batten Disease Sales and Growth Rate (2015-2020)
8.6 Italy Batten Disease Sales and Growth Rate (2015-2020)
8.7 Spain Batten Disease Sales and Growth Rate (2015-2020)
8.8 Russia Batten Disease Sales and Growth Rate (2015-2020)
9 Asia Pacific Batten Disease Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Batten Disease Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Batten Disease Sales by Countries (2015-2020)
9.2.2 Asia Pacific Batten Disease Revenue by Countries (2015-2020)
9.3 China Batten Disease Sales and Growth Rate (2015-2020)
9.4 Japan Batten Disease Sales and Growth Rate (2015-2020)
9.5 South Korea Batten Disease Sales and Growth Rate (2015-2020)
9.6 India Batten Disease Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Batten Disease Sales and Growth Rate (2015-2020)
9.8 Australia Batten Disease Sales and Growth Rate (2015-2020)
10 Middle East and Africa Batten Disease Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Batten Disease Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Batten Disease Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Batten Disease Revenue by Countries (2015-2020)
10.3 Saudi Arabia Batten Disease Sales and Growth Rate (2015-2020)
10.4 UAE Batten Disease Sales and Growth Rate (2015-2020)
10.5 Egypt Batten Disease Sales and Growth Rate (2015-2020)
10.6 Nigeria Batten Disease Sales and Growth Rate (2015-2020)
10.7 South Africa Batten Disease Sales and Growth Rate (2015-2020)
11 South America Batten Disease Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Batten Disease Sales, Revenue and Market Share by Countries
11.2.1 South America Batten Disease Sales by Countries (2015-2020)
11.2.2 South America Batten Disease Revenue by Countries (2015-2020)
11.3 Brazil Batten Disease Sales and Growth Rate (2015-2020)
11.4 Argentina Batten Disease Sales and Growth Rate (2015-2020)
11.5 Columbia Batten Disease Sales and Growth Rate (2015-2020)
11.6 Chile Batten Disease Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Seneb BioSciences.
12.1.1 Seneb BioSciences. Basic Information
12.1.2 Batten Disease Product Introduction
12.1.3 Seneb BioSciences. Production, Value, Price, Gross Margin 2015-2020
12.2 Abeo Therapeutics
12.2.1 Abeo Therapeutics Basic Information
12.2.2 Batten Disease Product Introduction
12.2.3 Abeo Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.3 Ionis Pharmaceuticals
12.3.1 Ionis Pharmaceuticals Basic Information
12.3.2 Batten Disease Product Introduction
12.3.3 Ionis Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.4 BioMarin Pharmaceuticals
12.4.1 BioMarin Pharmaceuticals Basic Information
12.4.2 Batten Disease Product Introduction
12.4.3 BioMarin Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.5 Evotec AG
12.5.1 Evotec AG Basic Information
12.5.2 Batten Disease Product Introduction
12.5.3 Evotec AG Production, Value, Price, Gross Margin 2015-2020
12.6 CereSpir Inc
12.6.1 CereSpir Inc Basic Information
12.6.2 Batten Disease Product Introduction
12.6.3 CereSpir Inc Production, Value, Price, Gross Margin 2015-2020
12.7 RegenxBio
12.7.1 RegenxBio Basic Information
12.7.2 Batten Disease Product Introduction
12.7.3 RegenxBio Production, Value, Price, Gross Margin 2015-2020
12.8 Mitochon Pharmaceuticals
12.8.1 Mitochon Pharmaceuticals Basic Information
12.8.2 Batten Disease Product Introduction
12.8.3 Mitochon Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.9 Spark Therapeutics
12.9.1 Spark Therapeutics Basic Information
12.9.2 Batten Disease Product Introduction
12.9.3 Spark Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.10 Polaryx Therapeutics
12.10.1 Polaryx Therapeutics Basic Information
12.10.2 Batten Disease Product Introduction
12.10.3 Polaryx Therapeutics Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Batten Disease Market Forecast
14.1 Global Batten Disease Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Occupational Therapies Market Value and Volume Forecast (2020-2025)
14.1.2 Physical Therapies Market Value and Volume Forecast (2020-2025)
14.2 Global Batten Disease Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Infantile NCL Market Value and Volume Forecast (2020-2025)
14.2.2 Late Infantile NCL Market Value and Volume Forecast (2020-2025)
14.2.3 Juvenile NCL Market Value and Volume Forecast (2020-2025)
14.2.4 Adult NCL Market Value and Volume Forecast (2020-2025)
14.3 Batten Disease Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter